- freely available
Systemic Therapy of Non-Resectable Metastatic Melanoma
AbstractIn advanced metastatic melanoma (non-resectable stage III/IV), the prognosis still remains poor, with median survival times between six and twelve months. Systemic therapeutic approaches for metastatic melanoma include chemotherapy, immunotherapy, immunochemotherapy, small molecules and targeted therapy. In this review, we will focus on the various treatment modalities as well as new agents used for targeted therapy.
Share & Cite This Article
Export to BibTeX | EndNote
MDPI and ACS Style
Orouji, A.; Goerdt, S.; Utikal, J. Systemic Therapy of Non-Resectable Metastatic Melanoma. Cancers 2010, 2, 955-969.View more citation formats
Orouji A, Goerdt S, Utikal J. Systemic Therapy of Non-Resectable Metastatic Melanoma. Cancers. 2010; 2(2):955-969.Chicago/Turabian Style
Orouji, Azadeh; Goerdt, Sergij; Utikal, Jochen. 2010. "Systemic Therapy of Non-Resectable Metastatic Melanoma." Cancers 2, no. 2: 955-969.